Amsurg (AMSG) Tops Q4 EPS by 4c, Offers Guidance

Amsurg (NASDAQ: AMSG) reported Q4 EPS of $0.77, $0.04 better than the analyst estimate of $0.73. Revenue for the quarter came in at $581.8 million versus the consensus estimate of $565.3 million.

Amsurg sees FY2015 EPS of $3.24-$3.32, versus the consensus of $3.27. Amsurg sees FY2015 revenue of $2.44-2.47 billion, versus the consensus of $2.39 billion.

Amsurg sees FY2015 EPS of $0.55-$0.58, versus the consensus of $0.75.

For earnings history and earnings-related data on Amsurg (AMSG) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c